LifePlan Financial Group’s AbbVie ABBV Stock Holding History

LifePlan Financial Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$11K	Hold	130	–	–	﹤0.01%	397
2020 Q2	$13K	Hold	130	–	–	0.01%	384
2020 Q1	$10K	Hold	130	–	–	0.01%	394
2019 Q4	$12K	Sell	130 -29	-18%	-$2.41K	0.01%	399
2019 Q3	$12K	Hold	159	–	–	0.01%	394
2019 Q2	$12K	Hold	159	–	–	0.01%	386
2019 Q1	$13K	Hold	159	–	–	0.01%	382
2018 Q4	$15K	Hold	159	–	–	0.01%	351
2018 Q3	$15K	Hold	159	–	–	0.01%	355
2018 Q2	$15K	Hold	159	–	–	0.01%	350
2018 Q1	$15K	Buy	+159	New	+$17.5K	0.01%	335

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

LifePlan Financial Group's ABBV Position: Q3 2020 in Review

LifePlan Financial Group held its AbbVie (ABBV) position steady in Q3 2020 at 130 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #397.

LifePlan Financial Group first reported a position in ABBV in Q1 2018 and has held it in 11 quarters since. The position peaked at $15K in Q4 2018. 2,366 funds tracked by Wall St. Rank hold ABBV as of Q3 2020.

LifePlan Financial Group held 130 shares of AbbVie worth $11K as of Q3 2020.
LifePlan Financial Group left its AbbVie share count unchanged in Q3 2020.
AbbVie made up ﹤0.01% of LifePlan Financial Group's portfolio in Q3 2020, its #397 holding.
LifePlan Financial Group first reported a position in AbbVie in Q1 2018 and has held it in 11 quarters since.
LifePlan Financial Group's AbbVie position peaked at $15K in Q4 2018.
2,366 funds tracked by Wall St. Rank held AbbVie as of Q3 2020.

Based on LifePlan Financial Group's 13F filing for Q3 2020, filed 30 Oct 2020.